NASDAQ:ATEC

Alphatec Stock Forecast, Price & News

$14.74
+0.09 (+0.61 %)
(As of 07/30/2021 12:00 AM ET)
Add
Compare
Today's Range
$14.52
$14.94
50-Day Range
$13.45
$15.99
52-Week Range
$4.87
$19.36
Volume272,071 shs
Average Volume588,603 shs
Market Capitalization$1.44 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.64
30 days | 90 days | 365 days | Advanced Chart
Receive ATEC News and Ratings via Email

Sign-up to receive the latest news and ratings for Alphatec and its competitors with MarketBeat's FREE daily newsletter.


Alphatec logo

About Alphatec

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; squadron lateral retractor designed to maximize patient outcomes; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System designed to improve surgical efficiency without compromising accuracy. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; solanas posterior cervico/thoracic fixation system and avalon occipital plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier. Further, it develops EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is based in Carlsbad, California.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

2.19 out of 5 stars

Medical Sector

129th out of 2,216 stocks

Surgical & Medical Instruments Industry

13th out of 185 stocks

Analyst Opinion: 2.5Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 5.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Alphatec (NASDAQ:ATEC) Frequently Asked Questions

Is Alphatec a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alphatec in the last twelve months. There are currently 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Alphatec stock.
View analyst ratings for Alphatec
or view top-rated stocks.

What stocks does MarketBeat like better than Alphatec?

Wall Street analysts have given Alphatec a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Alphatec wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Alphatec's next earnings date?

Alphatec is scheduled to release its next quarterly earnings announcement on Tuesday, August 3rd 2021.
View our earnings forecast for Alphatec
.

How can I listen to Alphatec's earnings call?

Alphatec will be holding an earnings conference call on Tuesday, August 3rd at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 416-621-4642 with passcode "4976259".

How were Alphatec's earnings last quarter?

Alphatec Holdings, Inc. (NASDAQ:ATEC) released its quarterly earnings data on Thursday, May, 6th. The medical technology company reported ($0.26) earnings per share for the quarter, missing analysts' consensus estimates of ($0.19) by $0.07. The medical technology company earned $44.12 million during the quarter, compared to the consensus estimate of $44.10 million. Alphatec had a negative net margin of 51.10% and a negative trailing twelve-month return on equity of 116.47%.
View Alphatec's earnings history
.

How has Alphatec's stock been impacted by Coronavirus (COVID-19)?

Alphatec's stock was trading at $4.41 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ATEC shares have increased by 234.2% and is now trading at $14.74.
View which stocks have been most impacted by COVID-19
.

What guidance has Alphatec issued on next quarter's earnings?

Alphatec issued an update on its second quarter 2021 earnings guidance on Monday, July, 26th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $55.80 million-$56.40 million, compared to the consensus revenue estimate of $44.82 million.

What price target have analysts set for ATEC?

6 brokerages have issued 12-month target prices for Alphatec's stock. Their forecasts range from $12.00 to $20.00. On average, they expect Alphatec's stock price to reach $16.50 in the next twelve months. This suggests a possible upside of 11.9% from the stock's current price.
View analysts' price targets for Alphatec
or view top-rated stocks among Wall Street analysts.

Who are Alphatec's key executives?

Alphatec's management team includes the following people:
  • Mr. Patrick S. Miles, Exec. Chairman, CEO & Pres (Age 55, Pay $1.46M)
  • Mr. Craig E. Hunsaker, Exec. VP of People & Culture, Corp. Sec. and Gen. Counsel (Age 57, Pay $711.95k) (LinkedIn Profile)
  • Mr. David P. Sponsel, Exec. VP of Sales (Age 42, Pay $794.18k)
  • Mr. J. Todd Koning, Chief Financial Officer (Age 48)
  • Mr. Scott Lish, Sr. VP of R&D (Age 40) (LinkedIn Profile)
  • Mr. Brian R. Snider, Exec. VP of Marketing (Age 43)
  • Mr. Jonathan Allen, Exec. VP of Commercial Operations (Age 61)
  • Dr. Luiz Pimenta, Chief Medical Officer
  • Ms. Kelli Mari Howell, Exec. VP of Clinical Strategies (Age 47)
  • Mr. Mark D. Ojeda, Exec. VP of Cervical & Biologics (Age 51)

What is Pat Miles' approval rating as Alphatec's CEO?

7 employees have rated Alphatec CEO Pat Miles on Glassdoor.com. Pat Miles has an approval rating of 72% among Alphatec's employees.

Who are some of Alphatec's key competitors?

What other stocks do shareholders of Alphatec own?

What is Alphatec's stock symbol?

Alphatec trades on the NASDAQ under the ticker symbol "ATEC."

How do I buy shares of Alphatec?

Shares of ATEC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Alphatec's stock price today?

One share of ATEC stock can currently be purchased for approximately $14.74.

How much money does Alphatec make?

Alphatec has a market capitalization of $1.44 billion and generates $144.86 million in revenue each year. The medical technology company earns $-78,990,000.00 in net income (profit) each year or ($1.18) on an earnings per share basis.

How many employees does Alphatec have?

Alphatec employs 296 workers across the globe.

What is Alphatec's official website?

The official website for Alphatec is www.atecspine.com.

Where are Alphatec's headquarters?

Alphatec is headquartered at 5818 EL CAMINO REAL, CARLSBAD CA, 92008.

How can I contact Alphatec?

Alphatec's mailing address is 5818 EL CAMINO REAL, CARLSBAD CA, 92008. The medical technology company can be reached via phone at 760-431-9286 or via email at [email protected]


This page was last updated on 7/30/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.